Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome

被引:47
作者
Berven, Frode S. [1 ]
Kroksveen, Ann C.
Berle, Magnus
Rajalahti, Tarja
Flikka, Kristian
Arneberg, Reidar
Myhr, Kjell-Morten
Vedeler, Christian
Kvalheim, Olav M.
Ulvik, Rune J.
机构
[1] Univ Bergen, Inst Med, N-5021 Bergen, Norway
[2] Univ Bergen, Dept Mol Biol, Bergen, Norway
[3] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
[4] Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway
[5] Univ Bergen PROBE, Proteom Unit, Bergen, Norway
[6] Univ Bergen, Dept Informat, N-5008 Bergen, Norway
[7] Pattern Recognit Syst AS, Bergen, Norway
[8] Univ Bergen, Ctr Integrated Petr Res, Bergen, Norway
[9] Univ Bergen, Dept Clin Med, Bergen, Norway
[10] Haukeland Hosp, Natl Competence Ctr Multiple Sclerosis, N-5021 Bergen, Norway
[11] Univ Bergen, Dept Chem, Bergen, Norway
[12] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway
关键词
biomarker discovery; cerebrospinal fluid; mass spectra; pre-analytical; principal component analysis;
D O I
10.1002/prca.200700126
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre-analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI-TOF MS was used to examine the influence of pre-analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 mu L blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut-off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut-off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at -80 degrees C without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein-protein interactions. A spin cartridge with cut-off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing stand-ardized pre-analytical protocols for the proteomic study of CSF.
引用
收藏
页码:699 / 711
页数:13
相关论文
共 29 条
[1]   Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum [J].
Albrethsen, Jakob ;
Bogebo, Rikke ;
Olsen, Jesper ;
Raskov, Hans ;
Gammeltoft, Steen .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (10) :1243-1252
[2]   Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry [J].
Banks, RE ;
Stanley, AJ ;
Cairns, DA ;
Barrett, JH ;
Clarke, P ;
Thompson, D ;
Selby, PJ .
CLINICAL CHEMISTRY, 2005, 51 (09) :1637-1649
[3]   Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis [J].
Berven, F. S. ;
Flikka, K. ;
Berle, M. ;
Vedeler, C. ;
Ulvik, R. J. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (03) :147-158
[4]   Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process? [J].
Carrette, O ;
Burkhard, PR ;
Hughes, S ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2005, 5 (12) :3060-3065
[5]  
Diamandis EP, 2005, CLIN CANCER RES, V11, P963
[6]  
Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO
[7]  
2-M
[8]   Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry [J].
Harper, RG ;
Workman, SR ;
Schuetzner, S ;
Timperman, AT ;
Sutton, JN .
ELECTROPHORESIS, 2004, 25 (09) :1299-1306
[9]   Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model [J].
Hood, BL ;
Lucas, DA ;
Kim, G ;
Chan, KC ;
Blonder, J ;
Issaq, HJ ;
Veenstra, TD ;
Conrads, TP ;
Pollet, I ;
Karsan, A .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2005, 16 (08) :1221-1230
[10]   Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? [J].
Hortin, GL .
CLINICAL CHEMISTRY, 2005, 51 (01) :3-5